Chronic Disease Prevention: Risk and Protective Factors

Quick Answer: Chronic disease prevention targets the leading causes of death — heart disease, cancer, COPD, diabetes, and stroke — by reducing modifiable risk factors (tobacco, poor diet, physical inactivity, harmful alcohol use) and strengthening protective factors (screening, medication adherence, healthy built environments). CPH items test the distinction between upstream social determinants, biological risk factors, and the three levels of prevention.

Leading Chronic Diseases and Their Burden

Five chronic diseases account for most U.S. mortality and disability. They share common behavioral risk factors, which is why CDC and WHO use a common risk factor approach:

Risk Factor Framework

Chronic disease risk factors operate at multiple levels:

• Behavioral: tobacco use, unhealthy diet, physical inactivity, harmful alcohol use — the "big four" responsible for the majority of preventable chronic disease burden.
• Biological and physiological: high blood pressure, high blood glucose, high LDL cholesterol, overweight and obesity — intermediate risk factors that mediate the behavior-to-disease pathway.
• Environmental: air pollution, food deserts, lack of walkability, marketing of tobacco and ultra-processed food.
• Genetic: family history of breast cancer, BRCA mutations, ApoE-ε4; not modifiable but informs screening intensity.
• Social determinants: income, education, neighborhood conditions, access to care, structural racism — upstream drivers of behavioral and biological risks.

Protective Factors

Protective factors lower risk or delay onset:

• Tobacco cessation — the single highest-impact intervention; quitting at any age adds life-years.
• Healthy diet — Mediterranean and DASH dietary patterns reduce cardiovascular events; high fiber lowers colorectal cancer risk.
• Regular physical activity — at least 150 minutes per week of moderate-intensity activity reduces cardiovascular disease, diabetes, and several cancers.
• Screening adherence — early detection of hypertension, high cholesterol, diabetes, and cancers shifts outcomes toward treatable stages.
• Vaccination against oncogenic infections — HPV vaccine prevents cervical and other cancers; HBV vaccine prevents liver cancer (a chronic disease prevented by an infectious-disease vaccine).
• Medication adherence — statins, antihypertensives, and metformin reduce events among high-risk individuals.

Levels of Prevention Applied to Chronic Disease

Worked example: A 52-year-old male smoker has blood pressure 148/96, LDL 160, and BMI 31. Primary intervention = tobacco cessation counseling plus a community smoke-free ordinance. Secondary = screen for and treat hypertension and hyperlipidemia; colonoscopy starting at age 45. Tertiary (once cardiovascular disease develops) = cardiac rehabilitation and statin titration. The population attributable fraction for smoking in COPD exceeds 80%, making tobacco control the highest-leverage primary-prevention investment.

Multi-Causality and the Web of Causation

Unlike single-agent infectious diseases, chronic diseases arise from many causes acting over decades. MacMahon and Pugh's web of causation maps behavioral, biological, environmental, and social factors interconnected across the life course. A PAF question may combine exposures: if obesity prevalence is 35% and the RR for type 2 diabetes is 7, PAF = 0.35 × 6 / [0.35 × 6 + 1] = 2.1 / 3.1 ≈ 68% of diabetes attributable to obesity in that population. Because real etiology is multi-causal, PAFs across overlapping exposures can sum to more than 100% — a single case can have multiple contributing causes.

Life-Course Perspective

Chronic disease risk accumulates from prenatal life onward. Low birth weight increases adult cardiovascular risk; childhood obesity predicts adult diabetes; adolescent tobacco use drives lifetime lung cancer risk. Prevention strategies therefore span the life course — prenatal care, school nutrition, adolescent HPV vaccination, adult screening, and elder chronic-disease management. Intervening early in the life course yields the largest cumulative benefit, because exposure years compound: a teenager who never starts smoking avoids decades of carcinogenic exposure that no adult cessation program can fully reverse.

Equity and the Upstream Lens

Chronic disease risk is not distributed equally. Lower-income communities face denser tobacco retail, fewer safe places to exercise, less access to fresh food, and higher exposure to air pollution. These upstream drivers sustain behavioral and biological risk factor gradients across the income and race spectrum. CPH items increasingly pair a clinical vignette with a structural determinant and ask which intervention addresses the cause of the causes — a soda tax or zoning reform addresses upstream determinants, while statin prescribing addresses a downstream biological risk factor.

Common Exam Traps

• Confusing primary with secondary prevention: mammography is secondary (detects existing disease), while smoke-free laws are primary (prevent disease onset).
• Treating hypertension as a disease rather than as a risk factor for cardiovascular and kidney disease.
• Ignoring overlap: HPV vaccination is both infectious disease primary prevention and cancer primary prevention.
• Assuming PAFs for overlapping multi-causal risks must sum to exactly 100%.